Effect of proinflammatory cytokines on the interplay between roxithromycin, HMR 3647, or HMR 3004 and human polymorphonuclear neutrophils

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 3, 2000, Pages 511-521

  Vazifeh, D ^a   Bryskier, A ^b   Labro, M T ^a  

^a BICHAT HOSPITAL   (France)

^b Hoechst Marion Roussel   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HMR 3004; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; ROXITHROMYCIN; SUPEROXIDE; TELITHROMYCIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG UPTAKE; HUMAN; HUMAN CELL; IMMUNOMODULATION; NEUTROPHIL; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CHLOROQUINE; CYTOKINES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; KETOLIDES; MACROLIDES; NEUTROPHILS; RESPIRATORY BURST; ROXITHROMYCIN; SUPEROXIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033996304     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.3.511-521.2000     Document Type: Article

References (40)

1. Abdelghaffar, H., D. Vazifeh, and M. T. Labro. 1997. Erythromycin A-derived macrolides modify the functional activities of human neutrophils by altering the phospholipase D-phosphatidate phosphohydrolase transduction pathway. J. Immunol. 159:3995-4005.
2. Bereta, J., M. Bereta, S. Cohen, and M. C. Cohen. 1991. Studies on the role of protein kinases in the TNF-mediated enhancement of murine tumor cell-endothelial cell interactions. J. Cell. Biochem. 47:62-78.
3. Bergmeyer, H. U., and E. Bernt. 1963. Lactate dehydrogenase, p. 737-739. In H. U. Bergmeyer (ed.), Methods in enzymatic analysis. Academic Press, Inc., New York, N.Y.
4. Bermudez, L. E., and L. S. Young. 1988. Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex. Antimicrob. Agents Chemother. 32: 1149-1153.
5. Bermudez, L. E., C. Inderlied, and L. S. Young. 1991. Stimulation with cytokines enhances penetration of azithromycin into human macrophages. Antimicrob. Agents Chemother. 35:2625-2629.
6. Bourgoin, S., P. E. Poubelle, N. W. Liao, K. Umezawa, P. Borgeat, and P. H. Naccache. 1992. Granulocyte-macrophage colony-stimulating factor primes phospholipase D activity in human neutrophils in vitro: role of calcium, G-proteins, and tyrosine kinases. Cell Signal. 4:487-500.
7. Bryskier, A., C. Agouridas, and J. F. Chantot. 1997. Ketolides: new semisynthetic 14-membered-ring macrolides, p. 39-50. In S. H. Zinner, L. S. Young, J. F. Acar, and H. C. Neu (ed.), Expanding indications for the new macrolides, azalides, and streptogramins. Marcel Dekker, Inc., New York, N.Y.
8. De Bont, E. S. J. M., A. Martens, J. Van Raan, G. Samson, W. P. F. Fetter, A. Okken, and L. H. F. M. de Leij. 1993. Tumor necrosis factor α, interleukin-1β and interleukin-6 plasma levels in neonatal sepsis. Pediatr. Res. 33:380-383.
9. Duong, M., M. Simard, Y. Bergeron, N. Ouellet, M. Côté-Richier, and M. G. Bergeron. 1998. Immunomodulating effects of HMR 3004 on pulmonary inflammation caused by heat-killed Streptococcus pneumoniae in mice. Antimicrob. Agents Chemother. 42:3309-3312.
10. Fresno, M., M. Kopf, and L. Rivas. 1997. Cytokines and infectious diseases. Immunol. Today 18:56-58.
11. Glimaker, M., P. Kragsberg, M. Forsgren, and P. Olcén. 1993. Tumor necrosis factor-α (TNF-α) in cerebrospinal fluid from patients with meningitis of different etiologies. High levels of TNF-α indicate bacterial meningitis. J. Infect. Dis. 167:882-889.
12. Gomez-Cambronero, J., J. M. Colasanto, C. K. Huang, and R. I. Sha'afi. 1993. Direct stimulation by tyrosine phosphorylation of microtubule-associated protein (MAP) kinase activity by granulocyte-macrophage colony-stimulating factor in human neutrophils. Biochem. J. 291:211-217.
13. Johnson, S. E., and C. Baglioni. 1990. Positive and negative regulation of a tumor necrosis factor response in melanoma cells. J. Biol. Chem. 265:6642-6649.
14. Kadota, J.-I., T. Iwashita, Y. Matsubara, Y. Ishimatsu, M. Yoshinaga, K. Abe, and S. Kohno. 1998. Inhibitory effect of erythromycin on superoxide anion production by human neutrophils primed with granulocyte colony-stimulating factor. Antimicrob. Agents Chemother. 42:1866-1867.
15. Kanakura, Y., B. Druker, S. A. Cannistra, Y. Furukawa, Y. Torimoto, and J. D. Griffin. 1990. Signal transduction of the human granulocyte-macrophage-stimulating factor and interleukin-3 receptor involves tyrosine phosphorylation of a common set of cytoplasmic proteins. Blood 76:706-715.
16. Khan, A. A., T. R. Slifer, F. G. Araujo, and J. S. Remington. 1999. Effect of clarithromycin and azithromycin on production of cytokines by human monocytes. Int. J. Antimicrob. Agents 11:121-132.
17. Labro, M. T. 1993. Immunomodulation by antibacterial agents. Is it clinically relevant? Drugs 45:319-328.
18. Labro, M. T. 1993. Effect of macrolides on host natural defenses, p. 389-408. In A. Bryskier, J. P. Butzler, H. C. Neu, and P. M. Tulkens (ed.), Macrolides: chemistry, pharmacology and clinical use. Arnette-Blackwell, Paris, France.
19. Labro, M. T. 1993. Intraphagocytic penetration of macrolide antibiotics, p. 379-388. In A. Bryskier, J. P. Butzler, H. C. Neu, and P. M. Tulkens (ed.), Macrolides: chemistry, pharmacology and clinical use. Arnette-Blackwell, Paris, France.
20. Labro, M. T. 1996. Immunomodulatory action of antibacterial agents. Clin. Immunother. 6:454-464.
21. Labro, M. T. 1997. Effects of macrolides on leukocytes and inflammation, p. 101-116. In S. H. Zinner, L. S. Young, J. F. Acar, and H. C. Neu (ed.), Expanding indications for the new macrolides, azalides, and streptogramins. Marcel Dekker, Inc., New York, N.Y.
22. Labro, M. T. 1998. Anti-inflammatory activity of macrolides: a new therapeutic potential? J. Antimicrob. Chemother. 41(Suppl. B):37-46.
23. Labro, M. T. 1998. Immunological effects of macrolides. Curr. Opin. Infect. Dis. 11:681-688.
24. Labro, M. T., and C. Babin-Chevaye. 1988. Effects of amodiaquine, chloroquine, and mefloquine on human polymorphonuclear neutrophil function in vitro. Antimicrob. Agents Chemother. 32:1124-1130.
25. Lazard, T., C. Perronne, Y. Cohen, J. Grosset, J.-L. Vilde, and J.-J. Pocidalo. 1993. Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice. Antimicrob. Agents Chemother. 37:692-695.
26. Liles, W. C., and W. C. Van Voorhis. 1995. Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. J. Infect. Dis. 172:1573-1580.
27. McColl, S. R., J. F. DiPersio, A. C. Caon, and P. H. Naccache. 1991. Involvement of tyrosine kinases in the activation of human peripheral blood neutrophils by granulocyte-macrophage colony-stimulating factor. Blood 78: 1842-1852.
28. McLeish, K. R., J. B. Klein, P. Y. Coxon, K. Z. Head, and R. A. Ward. 1998. Bacterial phagocytosis activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in human neutrophils. J. Leukoc. Biol. 64:835-844.
29. McLeish, K. R., C. Knall, R. A. Ward, P. Gerwins, P. Y. Coxon, J. B. Klein, and G. L. Johnson. 1998. Activation of mitogen-activated protein kinase cascades during priming of human neutrophils by TNF-α and GM-CSF. J. Leukoc. Biol. 64:537-545.
30. Ogle, J. D., J. G. Noel, R. M. Sramkoski, and C. K. Ogle. 1992. Adhesive effect of certain cytokines and other perturbants on human neutrophils. Inflammation 16:603-612.
31. Ouadrhiri, Y., B. Scorneaux, Y. Sibille, and P. M. Tulkens. 1999. Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon. Antimicrob. Agents Chemother. 43:1342-1351.
32. Porteu, F., and C. F. Nathan. 1990. Shedding of tumor necrosis factor receptors by activated human neutrophils. J. Exp. Med. 172:599-607.
33. Raghoebar, M., W. B. Van der Berg, and C. A. M. Van Ginneken. 1987. Alteration of chloroquine accumulation in human polymorphonuclear leucocytes under inflammatory conditions. Int. J. Tissue React. IX:255-261.
34. Spooner, C. E., N. P. Markowitz, and L. D. Saravolatz. 1992. The role of tumor necrosis factor in sepsis. Clin. Immunol. Immunopathol. 62:S11-S17.
35. Suzuki, K., M. Hino, F. Hato, N. Tatsumi, and S. Kitayama. 1999. Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor α. Blood 93:341-349.
36. Van der Poll, T., and H. P. Sauerwein. 1993. Tumour necrosis factor-α: its role in the metabolic response to sepsis. Clin. Sci. 84:247-256.
37. Van Deuren, M., J. van der Ven-Jongekrijg, A. K. M. Bartelink, R. van Dalen, R. W. Sauerwein, and J. W. M. van der Meer. 1995. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J. Infect. Dis. 172:433-439.
38. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411-452.
39. Vazifeh, D., H. Abdelghaffar, and M. T. Labro. 1997. Cellular accumulation of the new ketolide RU 64004 by human neutrophils: comparison with that of azithromycin and roxithromycin. Antimicrob. Agents Chemother. 41:2099-2107.
40. Vazifeh, D., A. Preira, A. Bryskier, and M. T. Labro. 1998. Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophils. Antimicrob. Agents Chemother. 42:1944-1951.